Choroidal metastases from thoracic cancer: a retrospective study on clinical characteristics and treatment efficacy
Lung and breast cancers are the leading sources of CMs, with bilateral or multifocal lesions more frequently linked to breast cancer. Treatment for CMs should be meticulously individualized and should take into account the patient's overall condition, tumor burden, and precise tumor location. Local treatment is essential for patients with significant ocular symptoms. A combination of local and systemic treatments has been shown to lead to a more significant reduction in tumor burden.
Authors
- Jianhong Liang (ORCID: https://orcid.org/0000-0002-6198-4125)
- Yong Cheng (ORCID: https://orcid.org/0000-0002-7529-4408)
- Haiping Li (ORCID: https://orcid.org/0000-0003-4677-5488)
- Yusheng Zhong
- Yajing Shi (ORCID: https://orcid.org/0009-0007-0040-1364)
- Ahui Liu
- Yating Yang (ORCID: https://orcid.org/0000-0001-5207-6742)
- Xiacheng Lin
Institutions
- Peking University (CN)
- Peking University People's Hospital (CN)
- Peking University Third Hospital (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-02-26
- DOI
- https://doi.org/10.3389/fmed.2025.1491278
- Citations
- 3
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.12